Financial Snapshot

Revenue
$278.0K
TTM
Gross Margin
-199.97%
TTM
Net Earnings
-$21.06M
TTM
Current Assets
Q3 2024
Current Liabilities
Q3 2024
Current Ratio
78.64%
Q3 2024
Total Assets
Q3 2024
Total Liabilities
Q3 2024
Book Value
-$18.53M
Q3 2024
Cash
Q3 2024
P/E
-2.019
Nov 29, 2024 EST
Free Cash Flow
-$26.80M
TTM

Revenues

Revenues

Loading...

Revenue YoY Change

Loading...

Revenues

Concept 2023 2022 2021 2020
Revenue $316.0K $0.00 $0.00 $0.00
YoY Change

Expenses

Cost Of Revenues

Loading...

Gross Profit

Loading...

Gross Profit Margin

Loading...

Gross Profit

Concept 2023 2022 2021 2020
Revenue $316.0K $0.00 $0.00 $0.00
Cost Of Revenue $789.0K $498.0K
Gross Profit -$473.0K -$498.0K
Gross Profit Margin -149.68%

Selling, General & Admin Expense

Loading...

Research & Development

Loading...

Depreciation, Depletion & Amortization

Loading...

SGA Expense to Gross Profit Ratio

Loading...

R&D To Gross Profit Ratio

Loading...

DDA To Gross Profit Ratio

Loading...

Operating Expenses Total

Loading...

Operating Profits/Loss

Loading...

Operational Expenses

Concept 2023 2022 2021 2020
Selling, General & Admin $8.942M $2.585M
YoY Change 245.92%
% of Gross Profit
Research & Development $8.956M $4.975M
YoY Change 80.02%
% of Gross Profit
Depreciation & Amortization $133.0K $75.00K
YoY Change 77.33%
% of Gross Profit
Operating Expenses $17.90M $4.888M $5.205M $0.00
YoY Change 266.15% -6.09%
Operating Profit -$18.37M -$4.888M -$5.205M
YoY Change 275.83% -6.09%

Interest Expenses

Loading...

Interest Expenses To Operating Income %

Loading...

Other Expense/Income

Loading...

Interest & Other Expense/Income

Concept 2023 2022 2021 2020
Interest Expense -$69.00K $26.12M $5.503M
YoY Change -100.26% 374.66%
% of Operating Profit
Other Income/Expense, Net -$11.47M -$498.8K -$550.0K
YoY Change 2199.12% -9.31%

Income/Loss

Pretax Income

Loading...

Income Tax

Loading...

Net Profits/Loss

Loading...

Pretax Income YoY Change

Loading...

Income Tax Rate

Loading...

Net Profits/Loss YoY Change

Loading...

Basic EPS

Loading...

Net Income To Revenue Ratio

Loading...

Pretax & Net Income

Concept 2023 2022 2021 2020
Pretax Income -$29.91M $20.74M -$251.6K $0.00
YoY Change -244.24% -8340.44%
Income Tax $1.502M
% Of Pretax Income 7.24%
Net Earnings -$29.91M $19.23M -$251.6K $0.00
YoY Change -255.5% -7743.56%
Net Earnings / Revenue -9464.56%
Basic Earnings Per Share -$2.38 -$1.57
Diluted Earnings Per Share -$2.38 $0.36 -$5.492K $0.00

Assets & Liabilities

Cash & Short-Term Investments

Loading...

Cash & Equivalents

Loading...

Cash To Operating Expenses Ratio

Loading...

Inventory

Loading...

Receivables

Loading...

Total Short-Term Assets

Loading...

Property, Plant And Equipment

Loading...

Long-Term Investments

Loading...

Total Long-Term Assets

Loading...

Total Assets

Loading...

Net Income To Total Assets Percentage

Loading...

Accounts Payable

Loading...

Short-Term Debt

Loading...

Long Term Debt Due

Loading...

Total Short-Term Liabilities

Loading...

Long-Term Debt

Loading...

Other Long-Term Liabilities

Loading...

Total Long-Term Liabilities

Loading...

Total Liabilities

Loading...

Short-Term To Long-Term Debt Ratio

Loading...

Short-Term Assets To Debt Ratio

Loading...

Long-Term Debt To Net Income Ratio

Loading...

Assets & Liabilities

Concept 2023 2022 2021 2020
Cash & Short-Term Investments $4.218M $107.8K $149.9K $30.00K
YoY Change 3813.89% -28.08% 399.5%
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets $957.0K $112.7K $713.3K
YoY Change 749.53% -84.21%
Inventory $1.404M
Prepaid Expenses
Receivables $70.00K
Other Receivables $176.0K
Total Short-Term Assets $6.825M $220.4K $863.2K $30.00K
YoY Change 2996.36% -74.46% 2777.23%
Property, Plant & Equipment $815.0K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $430.0M $425.0M
YoY Change 1.18%
Other Assets $353.7K $1.003M $90.00K
YoY Change -64.73% 1014.21%
Total Long-Term Assets $815.0K $430.4M $426.0M $90.00K
YoY Change -99.81% 1.02% 473278.28%
Total Assets $7.640M $430.6M $426.9M $120.0K
YoY Change
Accounts Payable $1.554M $1.178M $618.7K
YoY Change 31.97% 90.31%
Accrued Expenses $4.771M $3.946M $2.059M $100.0K
YoY Change 20.92% 91.59% 1959.43%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $1.500M $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $6.636M $7.310M $2.678M $100.0K
YoY Change -9.22% 172.94% 2578.17%
Long-Term Debt $0.00 $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.766M $11.48M $35.94M
YoY Change -75.9% -68.06%
Total Long-Term Liabilities $2.766M $11.48M $35.94M $0.00
YoY Change -75.9% -68.06%
Total Liabilities $9.402M $18.79M $38.62M $100.0K
YoY Change -49.96% -51.35% 38517.15%

Ownership

Basic Shares Outstanding

Loading...

Diluted Shares Outstanding

Loading...

Preferred Stock

Loading...

Treasury Stock Shares

Loading...

Stock Issuance & Repurchase

Loading...

Ownership Data

Concept 2023 2022 2021 2020
Basic Shares Outstanding 12.55M shares 10.12M shares
Diluted Shares Outstanding 12.55M shares 10.12M shares
Preferred Stock
Treasury Stock Shares

Return On Shareholders' Equity

Loading...

Book Value

Loading...

Free Cash Flow

Loading...

Free Cash Flow YoY

Loading...

Free Cash Flow Margin

Loading...

Dividends

Dividends

Loading...

Stock Price

Loading...
Market Cap: $42.514 Million

About Envoy Medical, Inc.

Envoy Medical, Inc. engages in designing, developing and marketing fully implantable medical devices that improve hearing. The company is headquartered in White Bear Lake, Minnesota and currently employs 34 full-time employees. The company went IPO on 2021-03-02. The firm is engaged in providing medical technologies across the hearing loss spectrum, all designed to shift the paradigm within the hearing industry and bring both providers and patients the hearing devices they require. Its hearing solutions include hearing aids, middle ear implants, bone conduction devices and cochlear implants. The bone conduction hearing device has two components: an external component and a surgically implanted fixture placed in the bone behind the ear. Its bone conduction hearing device offers amplification without ear mold in the ear. Its hearing aids are devices that amplify sound for those with mild to moderate hearing loss. Its Esteem is a fully implanted active middle ear implant designed to improve the hearing of adults diagnosed with moderate to severe sensorineural hearing loss. Cochlear implants are a solution for people with moderate-to-profound sensorineural hearing loss.

Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies Peers: ABBOTT LABORATORIES CUTERA INC Aspira Women's Health Inc. KNOW LABS, INC. Co-Diagnostics, Inc. DAXOR CORP IRIDEX CORP NEUROONE MEDICAL TECHNOLOGIES Corp Owlet, Inc.